Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Predictors and Clinical Characteristics of Relapses in LGI1-Antibody EncephalitisNeurology : neuroimmunology & neuroinflammation, 2024-05, Vol.11 (3), p.e200228-e200228 [Peer Reviewed Journal]EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200228 ;PMID: 38603771Full text available |
|
2 |
Material Type: Article
|
Antibodies Associated With Autoimmune Encephalitis in Patients With Presumed Neurodegenerative DementiaNeurology : neuroimmunology & neuroinflammation, 2023-09, Vol.10 (5) [Peer Reviewed Journal]Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200137 ;PMID: 37311646Full text available |
|
3 |
Material Type: Article
|
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum DisorderNeurology : neuroimmunology & neuroinflammation, 2024-01, Vol.11 (1), p.e200188-e200188 [Peer Reviewed Journal]Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200188 ;PMID: 38134369Full text available |
|
4 |
Material Type: Article
|
CXCL10/IgG1 Axis in Multiple Sclerosis as a Potential Predictive Biomarker of Disease ActivityNeurology : neuroimmunology & neuroinflammation, 2024-03, Vol.11 (2), p.e200200-e200200 [Peer Reviewed Journal]Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2024 American Academy of Neurology ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200200 ;PMID: 38346270Full text available |
|
5 |
Material Type: Article
|
Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic CriteriaNeurology : neuroimmunology & neuroinflammation, 2024-01, Vol.11 (1) [Peer Reviewed Journal]Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200183 ;PMID: 37977848Full text available |
|
6 |
Material Type: Article
|
Late-Onset Anti-GABA B Receptor Encephalitis: Clinical Characteristics and Outcomes Differing From Early-Onset PatientsNeurology : neuroimmunology & neuroinflammation, 2023-07, Vol.10 (4) [Peer Reviewed Journal]Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200131 ;PMID: 37230544Full text available |
|
7 |
Material Type: Article
|
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextNeurology : neuroimmunology & neuroinflammation, 2022-01, Vol.9 (1) [Peer Reviewed Journal]Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2021 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000001105 ;PMID: 34753829Full text available |
|
8 |
Material Type: Article
|
Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatmentNeurology : neuroimmunology & neuroinflammation, 2020-05, Vol.7 (3), p.e696-e696 [Peer Reviewed Journal]2020 American Academy of Neurology ;Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2020 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000000696 ;PMID: 32123047Full text available |
|
9 |
Material Type: Article
|
Retinal Optical Coherence Tomography in Neuromyelitis OpticaNeurology : neuroimmunology & neuroinflammation, 2021-11, Vol.8 (6) [Peer Reviewed Journal]Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2021 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000001068 ;PMID: 34526385Full text available |
|
10 |
Material Type: Article
|
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGADNeurology : neuroimmunology & neuroinflammation, 2023-01, Vol.10 (1) [Peer Reviewed Journal]Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2022 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200065 ;PMID: 36446614Full text available |
|
11 |
Material Type: Article
|
Arterial Spin Labeling Changes Parallel Asymmetric Perisylvian and Perirolandic Symptoms in 3 Pediatric Cases of Anti-NMDAR EncephalitisNeurology : neuroimmunology & neuroinflammation, 2023-07, Vol.10 (4) [Peer Reviewed Journal]Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200119 ;PMID: 37094999Full text available |
|
12 |
Material Type: Article
|
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 EncephalitisNeurology : neuroimmunology & neuroinflammation, 2021-05, Vol.8 (3) [Peer Reviewed Journal]Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2021 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000000974 ;PMID: 33848259Full text available |
|
13 |
Material Type: Article
|
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple SclerosisNeurology : neuroimmunology & neuroinflammation, 2024-05, Vol.11 (3), p.e200231-e200231 [Peer Reviewed Journal]Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2024 American Academy of Neurology ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200231 ;PMID: 38626360Full text available |
|
14 |
Material Type: Article
|
Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19Neurology : neuroimmunology & neuroinflammation, 2024-05, Vol.11 (3), p.e200244-e200244 [Peer Reviewed Journal]EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200244 ;PMID: 38630952Full text available |
|
15 |
Material Type: Article
|
Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR EncephalitisNeurology : neuroimmunology & neuroinflammation, 2023-07, Vol.10 (4) [Peer Reviewed Journal]Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200108 ;PMID: 37147137Full text available |
|
16 |
Material Type: Article
|
Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional AnalysisNeurology : neuroimmunology & neuroinflammation, 2022-05, Vol.9 (3) [Peer Reviewed Journal]Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000001147 ;PMID: 35217580Full text available |
|
17 |
Material Type: Article
|
Cardiac Involvement in Neurosarcoidosis: A Single-Center InvestigationNeurology : neuroimmunology & neuroinflammation, 2024-03, Vol.11 (2), p.e200196-e200196 [Peer Reviewed Journal]Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2024 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200196 ;PMID: 38181319Full text available |
|
18 |
Material Type: Article
|
Impact of Immune Checkpoint Inhibitors on the Course of Multiple SclerosisNeurology : neuroimmunology & neuroinflammation, 2024-03, Vol.11 (2), p.e200202-e200202 [Peer Reviewed Journal]Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2024 American Academy of Neurology ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200202 ;PMID: 38346268Full text available |
|
19 |
Material Type: Article
|
Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying TherapiesNeurology : neuroimmunology & neuroinflammation, 2023-01, Vol.10 (1) [Peer Reviewed Journal]Attribution - NonCommercial - NoDerivatives ;Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2022 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200064 ;PMID: 36414428Full text available |
|
20 |
Material Type: Article
|
Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before ConceptionNeurology : neuroimmunology & neuroinflammation, 2023-09, Vol.10 (5) [Peer Reviewed Journal]Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2023 American Academy of Neurology ;ISSN: 2332-7812 ;EISSN: 2332-7812 ;DOI: 10.1212/NXI.0000000000200161 ;PMID: 37550074Full text available |